Efficacy and Adverse Events of Docetaxel for Metastatic, Hormone-sensitive Prostate Cancer Among Elderly Men: A Post Hoc Analysis of the CHAARTED Trial-Reference-Cited by-同舟云学术

Efficacy and Adverse Events of Docetaxel for Metastatic, Hormone-sensitive Prostate Cancer Among Elderly Men: A Post Hoc Analysis of the CHAARTED Trial

Published:2021-10 Issue:5 Volume:19 Page:388-395
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Li Eric V.,Siddiqui Mohammad R.,Weiner Adam B.,Prizment Anna E.,Ryan Charles J.,Morgans Alicia K.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference17 articles.

1. Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland;Huggins;Arch Surg,1941

2. Metastatic castration-sensitive prostate cancer: abiraterone, docetaxel, or;Barata;Cancer,2019

3. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial;Kyriakopoulos;J Clin Oncol,2018

4. Quality of life during treatment with chemohormonal therapy: analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer;Morgans;J Clin Oncol,2018

5. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemtherapie des Prostatakarzinoms im hohen Alter;Die Onkologie;2024-01-26

2. MRI-measured adipose features as predictive factors for detection of prostate cancer in males undergoing systematic prostate biopsy: a retrospective study based on a Chinese population;Adipocyte;2022-11-24